Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Theta Burst Stimulation for motor impairment after stroke
ISRCTN ISRCTN03884521
ClinicalTrials.gov identifier
Public title Theta Burst Stimulation for motor impairment after stroke
Scientific title Enhancing the effect of physical therapy for motor impairment after stroke with Theta Burst Stimulation
Acronym TBS Study
Serial number at source 3279; G0401353
Study hypothesis In this study we plan to investigate whether brain stimulation can be used as an add-on treatment to consolidate the benefit from patterned upper limb physiotherapy and induce further hand motor improvement in chronic stroke patients.

To stimulate the brain we plan to use Theta Burst Stimulation (TBS), a novel paradigm of repetitive transcranial magnetic stimulation (TMS), aiming to increase cortical excitability of the affected (ipsilesional) hemisphere.

According to evidence so far, we believe that increased ipsilesional excitability can be achieved by:
1. Direct facilitation of the affected hemisphere (ipsilesional facilitation)
2. Inhibition of the unaffected hemisphere (contralesional inhibition)

Primary aim:
To investigate whether daily treatment with TBS followed by patterned physical therapy for a period of two weeks can lead to significant and sustained improvement of hand motor behavior in chronic stroke patients.

Secondary aims:
1. To study the physiological correlates of the potential behavioral gains
2. To identify physiological predictors of likelihood of response to the proposed intervention, so that appropriate patients may be targeted in future trials

Physiological correlates will be studied using TMS and functional magentic resonance imaging (fMRI) as detailed below.
Lay summary
Ethics approval NHNN and ION Joint Research Ethics Committee approved on the 25/02/2005 (ref: 04/Q0512/108)
Study design Randomised interventional treatment trial
Countries of recruitment Italy, United Kingdom
Disease/condition/study domain Topic: Stroke Research Network; Subtopic: Rehabilitation; Disease: Therapy type
Participants - inclusion criteria 1. History of a single ischaemic stroke, initially affecting the hand
2. Minimum interval since stroke onset one year (no upper limit)
3. Residual impairments of hand function (strength and/or dexterity)
4. Some degree of hand movement defined as present wrist extension (>=20%) and ability to grasp
5. Capable of giving informed consent
6. Aged 18 - 80 years, either sex
Participants - exclusion criteria 1. Intracerebral hemorrhage
2. Large ischaemic lesions involving almost the whole MCA territory
3. Significant tone problems in the hand (greater than 2 in the Ashworth Scale)
4. Severe cognitive impairment defined as mini-mental state examination (MMSE) less than 20
5. Residual aphasia or visual field defect (greater than or equal to 2 in the relative item of the National Institutes of Health Stroke Scale [NIHSS])
6. Past or current history of other neurological or psychiatric disease including epilepsy, previous or recurrent stroke and peripheral neuropathy
7. Major systemic illness
8. Use of anticonvulsant, psychotropic or sedative or medication
9. Excessive use of alcohol or other substances
10. Accepted contraindications for TMS (presence of metal in the head (excluding the mouth), intracardiac lines, cardiac pacemakers)
Anticipated start date 01/11/2005
Anticipated end date 31/12/2010
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Planned Sample Size: 45
Interventions Physical therapy (physiotherapy):
The protocol for physical therapy has been developed in collaboration with the therapy services department at the National Hospital for Neurology and Neurosurgery. It expands upon previous protocols by ensuring the equivalence of task intensity, repetition rate and verbal feedback across subjects. Treatment will be task oriented and individualised based on the findings of a questionnaire about current functional difficulties and an objective examination.

Theta Burst Stimulation:
TMS is a well tolerated method of stimulating the human cortex through the intact scalp. We will employ a new pattern of repetitive TMS called Theta Burst Stimulation (TBS). Each burst consists of 3 low intensity (80% aMT, see further on) stimuli, repeating at high frequency (50Hz). Bursts are repeating at 5Hz, i.e. the "theta" rhythm of the EEG. A total of 15 pulses are delivered per second. TBS effect on corticospinal excitability can be either inhibitory of facilitatory, depending on the pattern.

Follow up length: 3 months
Study entry: single randomisation only
Primary outcome measure(s) Action Research Arm Test, measured at initial assessment, 2 day post-intervention follow-up, 1 month follow-up and 3 month follow-up.
Secondary outcome measure(s) 1. Electrophysiological measures of corticospinal excitability, intracortical interactions and interhemispheric balance, measured at initial assessment, 2 day post-intervention follow-up, 1 month follow-up and 3 month follow-up
2. Functional Magnetic Resonance Imaging: Measurement of motor and sensory related brain activation only performed at initial and two day post intervention follow-up
Sources of funding Medical Research Council (MRC) (UK) (ref: G0401353)
Trial website
Publications
Contact name Ms  Ulrike  Hammerbeck
  Address Institute of Neurology
Queen Square London
Queen Square
  City/town London
  Zip/Postcode WC1N 3BG
  Country United Kingdom
Sponsor University College London Hospitals NHS Foundation Trust (UK)
  Address Joint UCLH/UCL Biomedical Research Unit
1st Floor Maple House
149 Tottenham Court Road
  City/town London
  Zip/Postcode W1P 9LL
  Country United Kingdom
  Sponsor website: http://www.uclh.nhs.uk/
Date applied 29/04/2010
Last edited 10/05/2010
Date ISRCTN assigned 29/04/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central